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1. Introduction 
The efflux of calcium from calcium loaded sarco- 
plasmic vesicles into solutions containing low free 
calcium concentrations gives rise to the formation 
of a phosphorylated intermediate in the membranes, 
the phosphoryl group of which can be transferred 
readily to ADP [ 1,3 ] . Hence, under steady state 
conditions when the slow calcium efflux is balanced 
by an ATP driven calcium influx a slow exchange 
between inorganic phosphate and the y-P of ATP 
takes place [2] . When the calcium influx ceases 
because the energy donators are exhausted or re- 
moved, the rate of net calcium efflux i.e. the rate 
of calcium release remains low as long as there is 
no ADP present to serve as phosphate acceptor. The 
transfer of the phosphoryl group to ADP, however, 
leads to a tremendous acceleration of calcium re- 
lease which is stoichiometrically related to a net 
formation of ATP [3]. The calcium efflux depen- 
dent ATP formation is neither uncoupled by di- 
nitrophenol nor by azide. On the other hand, all 
treatments which increase the calcium permeability 
of the sarcoplasmic membranes by leak formation 
abolish the osmochemical energy transduction 
irreversibly. This paper reports the reversible un- 
coupling of the calcium gradient dependent phos- 
phoryl transfer by arsenate, the classical uncoupler 
of substrate linked and oxidative phosphorylation. 
* To whom to address correspondence. 
Abbreviation: 
EGTA: Ethyleneglycol-2-(2-aminoethyl)-tetraacetic cid. 
North-Holland Publishing Company - Amsterdam 
2. Methods 
Sarcoplasmic vesicles prepared and purified 
according to Hasselbach and Makinose [4] were 
loaded with 4scalcium oxalate or 4s calcium phos- 
phate with ATP or acetyl phosphate as energy 
donator as described by Hasselbach and Makinose 
[3]. The release of calcium was started after the 
vesicles had used up the energy donators by the 
addition of a small volume of the solution contain- 
ing the substance whose releasing activity should be 
tested. Details are given in the legends. When the 
calcium release should be studied in media of low 
phosphate or oxalate content the uptake media 
were diluted lo-30 fold. 
Calcium release was followed by millipore fil- 
tration of the vesicle suspension at appropriate 
time intervals. The 4s calcium radioactivity in the 
millipore filtrate was measured by liquid scintilla- 
tion counting. The phosphate of ATP formed from 
inorganic “phosphate and ADP during calcium re- 
lease was transferred to glucose (0.1 M). Hexokinase 
(EC 2.7.1 .l) (0.01-0.02 mg/ml) was introduced 
together with the releasing solutions. The reaction 
was terminated by adding 2 ml 6% trichloracetic 
acid. After the removal of excess =phosphate accord- 
ing to Avron [5] the radioactivity of glucoseB- 
phosphate and ATP were measured by liquid scin- 
tillation counting. Hexokinase (EC 2.7.1.1) and 
pyruvate kinase (EC 2.7.1.40) was obtained from 
Boehringer, Mannheim/Germany. 
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Fig. 1. The depletion of different solutions from calcium by 
sarcoplasmic vesicles in the presence and in the absence of 
arsenate. Ordinate: calcium concentration in the solution 
(mM), abscissa: time (min). Composition of the calcium up- 
take media: all assays contained: 0.1 mg ves. prot./ml, 20 
mM histidine, 40 mM KCl, S mM MgClz, pH 7.0,O.l mM 
CaCIz . 
Assay (1): 2 mM K-Li-acetyl phosphate, 3 mM K-oxalate; 
Assay (2): 2 mM K-Li-acetyl phosphate, 20 mM Na-phosphate; 
Assay (3): 2 mM K-Liacetyl phosphate, 5 mM Na-phosphate; 
Assay (4): 0.01 mM ATP, 3 mM K-phosphoenolpyruvate, 
0.01 mg/ml pyruvate kinase, 10 mM Na-phos- 
phate; 
Arsenate (mM): (X-X-X): none; (m-*-m): 0.1; (o-o-o): 
1.0; (A-A-A): 5. 
3. Results 
As illustrated in fig. 1 arsenate does not affect the 
uptake of calcium by the sarcoplasmic vesicles. This 
ineffectiveness of arsenate depends neither on the 
kind nor on the concentration of the energy donator, 
nor on the calcium precipitating anion present in the 
solution, oxalate or phosphate. Likewise, the total 
calcium concentration found in the solution after the 
cessation of net calcium uptake is not affected sig- 
nificantly by arsenate. However, on addition of 
0.1-0.3 mM EGTA to the suspension after net cal- 
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Fig. 2. Arsenate induced calcium release and its abolition by 
magnesium removal. Ordinate: calcium concentration in the 
solution (mM), abscissa: time (min). Sarcoplasmic vesicles 
(0.1 mg prot./ml) were loaded with calcium phosphate for 
15 min [3]. The uptake media of 40 ml contained: 2 mM K- 
Li-acetyl phosphate, 5 mM MgCl2, 20 mM histidine, 40 mM 
KCI, 20 mM Na-phosphate, pH 7.0,O.l mM CaQ. Calcium 
uptake was followed by taking 5 samples of 2 ml at appro- 
priate time intervals. The release was started by the addition 
of 1.5 -2.5 ml of the respective test solution to 30 ml uptake 
medium. The concentrations of the different reagents in the 
test solution were chosen in such a way that they were pres- 
ent in the following final concentrations in these assays: 
(0-o-o): 2 mM EGTA; (m---m): 2 mM EGTA, 5 mM Na- 
arsenate;(r-r-r): 2 mM EGTA, 10 mM EDTA, 5 mM Na- 
arsenate. The pH of the added solutions were adjusted so that 
pH of the assay remained unchanged. 
cium uptake has stopped, more calcium is released in 
the presence of arsenate than in its absence. The en- 
hanced calcium release results in a higher free calcium 
concentration in the newly attained steady state in- 
dicating a reduction of the concentrating ability of 
the vesicles produced by arsenate. While with phos- 
phate as calcium precipitating anion and ATP as 
energy donator the free calcium concentration rises 
only by 30-60% from 0.03 PM to - 0.05 PM, it 
approaches 0.2 PM when the energy is delivered by 
acetyl phosphate. 
In line with these observations, arsenate stimulates 
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Table 1 
The inhibition of the arsenate induced 
calcium release by ADP. 
Relative 
release rate 
(VA) 
0 100 
0.3 100,100 
1.0 35, 51 
2.0 27, 31 
A procedure was used to estimate the influence of ADP 
which allowed the removal of calcium precipitating anions 
from the solution because phosphate as well as oxalate inter- 
fere with ADP inhibition. The sarcoplasmic vesicles were 
loaded with calcium oxalate for 10 min in solutions con- 
taining 2 mM ATP, 5 mM MgC12, 5 mM K-oxalate, 40 mM 
KCl, 20 mM histidine, pH 7.0,O.l mM 45CaClZ, 0.2 mg 
prot./ml. 2 ml of the suspension were sucked through a 
millipore filter and subsequently the vesicles caught in the 
filter were rinsed successively with 5 ml of the following 
solutions which all contained 5 mM MgClz, 20 mM histidine, 
pH 7.0: a) 100 mM KC1 (2 times); b) 5 mM EGTA, 40 mM 
KCl; c) 5 mM EGTA, 2 mM Naarsenate, 40 mM KCl; and 
d) 5 mM EGTA, 2 mM Na-arsenate, 40 mM KC1 plus 2.0 mM, 
1.0 mM, 0.3 mM ADP, respectively. The filtration rate was 
adjusted to approximately 5 ml/min. Solutions a and b 
liberate Va = Vb = 0.05 pmoles Ca/mg prot./min. The re- 
lease rate was increased by solution c to Vc = 0.15 ).tmoles 
Ca/mg prot./min. In solution d the release rate Vd declines 
depending on its ADP content. Controls were performed 
showing that the results were not dependent on whether 
solutions c or d were applied at first. The relative release rates 
given in the table are defined as follows: 
Frer. 
vc - vb 
=- x 100. 
vd - ‘b 
calcium efflux from calcium loaded vesicles in the 
absence of energy donators as shown in fig. 2. This 
enhancement of the release is as marked as that pro- 
duced by the combined action of ADP and phosphate 
[I] . While ADP is not required for the arsenate effect, 
magnesium ions must be present. The arsenate in- 
duced calcium release is completely reversible. Cal- 
cium release stops immediately and calcium uptake 
starts to re-occur if the system is supplemented with 
ATP. 
The arsenate induced calcium release is inhibited 
by ADP as well as by phosphate. The inhibition pro- 
duced by ADP is difficult to measure quantitatively 
because it shows up clearly only in the absence of 
phosphate or oxalate. The data given in table 1 were 
obtained from vesicles precipitated on millipore 
filters for the complete removal of the phosphate- 
containing uptake medium. The concentration re- 
quired for half maximal inhibition is in the order of 
1 mM ADP (table 1). On the other hand, the inhibi- 
tion of phosphate could be analyzed in more detail. 
As shown by fig. 3 the inhibition of the arsenate in- 
duced calcium release by phosphate is noncompeti- 
tive. The apparent affinity constant K, for arsenate 
has a value of 8 mM at 20” and 2 mM at 30”, indi- 
cating an endothermic binding reaction with an 
enthalpy change of 24,600 Cal/mole. The inhibition 
constant Ki for phosphate, Ki = 2 mM, corresponds 
approximately to the concentration of phosphate 
giving rise to a half maximal activation of the phos- 
phate-ADP induced calcium efflux [6] . The inhibi- 
tion constant K, does not, or only little, change with 
Fig. 3. Double reciprocal plot for the activation of calcium 
release by arsenate and its inhibition by phosphate at 20” and 
30”. Ordinate: reciprocal rate of calcium release (‘) 
[V] = pmoles calcium/mg prot/min, abscissa: recik;ocal 
arsenate concentration [As] = mM. Composition of the up; 
take assays as described in fig. 1 except for the concentrations 
of phosphate which were varied: (e-o-o): 5 mM; (T-W-T): 
10 mM; (A-A-A): 20 mM. Calcium release was started by the 
addition of 1.5-2.5 ml of a concentrated arsenate solution. 
The release rate was measured as described in Methods. 
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Fig. 4. Inhibition of inorganic phosphate incorporation into 
ADP during arsenate induced calcium release. The vesicles 
were loaded for 15 min with calcium oxalate in solutions 
containing: 0.5 mg ves. prot/ml, 0.5 mM 45CaC12, 1 mM K- 
oxalate, 1 mM Na-phosphate, 2 mM K-Li-acetyl phosphate, 
7 mM MgCla, 40 mM KCl, 100 mM glucose, volume 30 ml. 
Under these conditions the calcium load remained low 
- 0.3-0.5 pmoles calcium/mg prot. Calcium uptake was 
followed by 3 determinations. Calcium release was initiated 
by adding 6 ml releasing solution to the remaining 24 ml 
of the uptake medium. The releasing solution contained: 
10 mM EGTA, 1 mM Na-phosphate, 2.5 mM ADP, 100 mM 
glucose, 0.6 mg hexokinase, pH 7.0. The arsenate medium 
contained in addition 25 mM Na-arsenate. The time course 
of calcium release was followed by the millipore filtration 
technique. For the measurement of P-incorporation aliquots 
were taken and added to eqwdl volumes of 6% TCA to ter- 
minate the reaction. P-incorporation was measured by the 
formation of glucose-6-phosphate which was determined 
according to Avron [S] .Calcium release: (v-v--v): with 
arsenate, (X-X-X): without arsenate. Glucose-6-phosphate 
formation: (A-A-A): with arsenate, (o-e-e): without 
arsenate. 
temperature. In spite of the different effects of 
temperature on arsenate and phosphate binding, 
the temperature coefficient of the arsenate and the 
phosphate-ADP induced calcium release prove to 
be identical: Qr ,-, = 2.5_3.0 between 20” and 30”. 
The suspected uncoupling of calcium release from 
phosphate incorporation into ADP by arsenate proves 
difficult to demonstrate. In the presence of high con- 
centrations of phosphate and/or ADP arsenate does 
not give rise to an increase of calcium release because 
ADP and inorganic phosphate compete with arsenate. 
Therefore, the incorporation of inorganic phosphate 
Table 2 
Effect of arsenate on orthophosphate incorporation into 
the sarcoplasmic membranes. 
Conditions Phosphate incorporated into lo6 g 
membrane protein 
(moles) 
EGTA 
absent 
Before the After the 
addition of addition of 
arsenate arsenate 
2.0 1.0 
EGTA 
present 
2.1 0.7 
Inorganic phosphate was incorporated into the protein of 
the sarcoplasmic vesicles under the same conditions which 
give rise to the formation of ATP from Pi and ADP [3]. 
The assays contained 0.5 mg prot/ml, 2 mM acetyl phos- 
phate, 5 mM MgCls, 40 mM KCI, 5 mM 32(P) Na-phosphate 
and 0.2 mM CaClz, pH 7.0. When net calcium uptake ceased 
after 15 min at 20”, 2 mM Na-arsenate was added to the 
mixture. In the second experiment 1 mM EGTA was added 
2 min before the addition of arsenate. Immediately before 
and after the arsenate addition the 32P-incorporation into 
the membrane protein was measured [lo]. 
into ATP is not affected. The uncoupling effect of 
arsenate can be detected only when calcium release 
and phosphate incorporation are submaximally ac- 
tivated by low concentrations of phosphate andADP. 
Under these conditions calcium release is enhanced 
by arsenate and the formation of ATP is completely 
abolished (fig. 4). At intermediate phosphate con- 
centrations arsenate reduces phosphate incorpora- 
tion partially. As the described experiments suggest, 
the formation of a phosphorylated intermediate in 
the membranal protein is suppressed during calcium 
release stimulated by arsenate (table 2). 
4. Discussion 
As to be expected from numerous observations 
showing that the substitution of phosphate by 
arsenate leads to an uncoupling of the substrate 
linked as well as the respiratory chain phosphoryla- 
tion (cf. [7] ), arsenate uncouples calcium efflux 
dependent phosphorylation in the sarcoplasmic 
membranes. This uncoupling gives rise to a consider- 
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able acceleration of the calcium efflux. The concen- 
trations of arsenate which produce this effect are 
somewhat lower than those effecting substrate linked 
and oxydative phosphorylation [7]. The effect of 
arsenate is counteracted by phosphate in approximate- 
ly the same concentration range. However, the in- 
hibition of the arsenate induced calcium efflux by 
phosphate is not competitive as one should assume 
if arsenate and phosphate react at the same site of 
the calcium transport system. The differences between 
the interaction of phosphate and arsenate are revealed 
most clearly by the fact that the binding of arsenate 
is highly endothermic and consequently driven by a 
large enthropy increase. In contrast, phosphate bind- 
ing is thermoneutral. The inhibition of the arsenate 
induced calcium release by ADP is another fact diffi- 
cult to reconcile with a simple replacement of phos- 
phate by arsenate as proposed for the mechanism of 
the arsenate stimulated respiration of mitochondria 
]71. 
The different effects which arsenate exerts on the 
calcium transport system in the steady state, depend- 
ing on the energy donator by which the transport is 
supported, suggest a more complex mechanism in 
which not only phosphate but also the energy dona- 
tors and their splitting products are involved (cf. 
[g] ). While the ATP driven calcium pump in the 
steady state is only little effected when arsenate is 
present and the free calcium concentration is reduced 
by EGTA, the pump supported by acetyl phosphate 
releases the stored calcium nearly completely. Ob- 
viously, the efflux induced by arsenate cannot be 
compensated by the acetyl phosphate supported 
pump when the calcium concentration outside is 
lowered by EGTA. This is because the acetyl phos- 
phate supported.pump has a very low optimal trans- 
port rate and it needs a much higher calcium con- 
centration for activation than the ATP supported 
pump [9]. An explanation for the ineffectiveness 
of arsenate in the ATP supported system may be 
found in the observation described in table 2 show- 
ing that ADP counteracts the arsenate induced cal- 
cium release. Obviously ATP acts not only as a phos- 
phate and energy donator like acetyl phosphate, but 
ATP as well as its splitting product ADP are at the 
same time powerful modifiers of the calcium pump. 
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